Axxcess Wealth Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
29,860
-978
| -3% | -$1.21K | ﹤0.01% | 876 |
|
|
2025
Q1 | $36.4K | Sell |
30,838
-2,630
| -8% | -$3.1K | ﹤0.01% | 841 |
|
|
2024
Q4 | $61.2K | Sell |
33,468
-1,237
| -4% | -$2.26K | ﹤0.01% | 842 |
|
|
2024
Q3 | $59K | Sell |
34,705
-43
| -0.1% | -$73 | ﹤0.01% | 879 |
|
|
2024
Q2 | $47.6K | Sell |
34,748
-427
| -1% | -$585 | ﹤0.01% | 834 |
|
|
2024
Q1 | $132K | Buy |
35,175
+13,382
| +61% | +$50.2K | ﹤0.01% | 841 |
|
|
2023
Q4 | $214K | Buy |
21,793
+3,513
| +19% | +$34.5K | 0.01% | 761 |
|
|
2023
Q3 | $153K | Buy |
18,280
+3,494
| +24% | +$29.2K | 0.01% | 756 |
|
|
2023
Q2 | $197K | Buy |
14,786
+86
| +0.6% | +$1.14K | 0.01% | 556 |
|
|
2023
Q1 | $170K | Buy |
14,700
+3,221
| +28% | +$37.3K | 0.01% | 598 |
|
|
2022
Q4 | $93.9K | Sell |
11,479
-5,438
| -32% | -$44.5K | 0.01% | 595 |
|
|
2022
Q3 | $98K | Sell |
16,917
-1,066
| -6% | -$6.18K | 0.01% | 519 |
|
|
2022
Q2 | $79K | Buy |
17,983
+2,564
| +17% | +$11.3K | 0.01% | 518 |
|
|
2022
Q1 | $140K | Sell |
15,419
-2,326
| -13% | -$21.1K | 0.01% | 602 |
|
|
2021
Q4 | $363K | Buy |
+17,745
| New | +$363K | 0.03% | 426 |
|